[Possibilities and problems in the synchronization therapy of malignant tumours (author's transl)]. 1976

J Elö

New cell kinetic research results promise successful possibilities in conservative tumour therapy. The sensitivity towards radiation and many cytostatic agents is phase dependent so that the possibility must be found to receive a homogenous cell population. Following partial synchronization a cell phase specific tumour therapy can be initiated. We use the synchronized radiation therapy since 4 years. The results in 24 patients treated up to now are not significant. The basic priniciple is clear, but there are still many unsolved problems.

UI MeSH Term Description Entries
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

J Elö
January 1974, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
J Elö
January 1981, Radiobiologia, radiotherapia,
J Elö
January 1973, Radiobiologia, radiotherapia,
J Elö
March 1974, Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology,
J Elö
May 1974, Sbornik lekarsky,
J Elö
January 1977, Zentralblatt fur Chirurgie,
J Elö
June 1981, Wiener klinische Wochenschrift,
J Elö
October 1977, Nippon Ganka Gakkai zasshi,
Copied contents to your clipboard!